Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression

While chemotherapy delivery by nanocarriers has modestly improved the survival prospects of pancreatic ductal adenocarcinoma (PDAC), additional engagement of the immune response could be game changing. We demonstrate a nano-enabled approach for accomplishing robust anti-PDAC immunity in syngeneic mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jianqin, Liu, Xiangsheng, Liao, Yu-Pei, Salazar, Felix, Sun, Bingbing, Jiang, Wen, Chang, Chong Hyun, Jiang, Jinhong, Wang, Xiang, Wu, Anna M., Meng, Huan, Nel, Andre E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703845/
https://www.ncbi.nlm.nih.gov/pubmed/29180759
http://dx.doi.org/10.1038/s41467-017-01651-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703845/
https://www.ncbi.nlm.nih.gov/pubmed/29180759
http://dx.doi.org/10.1038/s41467-017-01651-9

Ejemplares similares